AceRNA Technologies
Kyoto
About AceRNA Technologies
AceRNA contributes to regenerative medicine and drug discovery through the discovery of novel miRNA functions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.8M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2024)
- Website: acernatec.com
- Phone: +81 075-757-6234
Industries & Categories
Biopharma, Biotechnology, Genetics, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/acerna-technologies-59679 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.